Thursday-Abstracts
Thursday-Abstracts
Thursday-Abstracts
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Thursday</strong>, May 30, 2013<br />
S298 Vol. 45 No. 5 Supplement<br />
1529 Board #121 May 30, 2:00 PM - 3:30 PM<br />
Examination of sustained Gait speed in Individuals with<br />
Chronic stroke<br />
Tracy A. Dierks1 , Peter A. Altenburger1 , Kristine K. Miller2 ,<br />
Rebecca L. Phipps3 , Arlene A. Schmid2 . 1Indiana University,<br />
Indianapolis, IN. 2Roudebush VA Medical Center, Indianapolis,<br />
IN. 3Indiana University Health, Indianapolis, IN. (Sponsor:<br />
Stuart J. Warden, FACSM)<br />
(No relationships reported)<br />
While improvements in gait speed are commonly achieved following therapy for<br />
individuals with stroke, many in the chronic stages still experience gait deficits,<br />
causing declines in community ambulation. This may be associated with an inability to<br />
sustain gait speed for an extended period of walking, yet little is known regarding gait<br />
speed sustainability.<br />
PurPOsE: To determine if individuals with chronic stroke have the ability to sustain<br />
gait speed for 6 minutes of walking.<br />
METhOds: Forty-five individuals with chronic stroke completed a 10 meter walk<br />
test (10MWT) and 6 minute walk test (6MWT) over a gait mat. For the 10MWT,<br />
subjects walked at the fastest pace possible that felt safe. For the 6MWT, subjects<br />
walked at a comfortable pace for 6 minutes while traversing a 30-meter walkway,<br />
allowing for multiple passes over the gait mat. Gait speed sustainability was measured<br />
as the difference between the peak speed during the 6MWT and the speed at the end.<br />
rEsuLTs: The 6MWT peak speed (0.89 m/s ±0.38) was significantly slower than the<br />
10MWT speed (1.06 m/s ±0.51), suggesting subjects were capable of selecting a fast<br />
pace versus one for extended walking. Yet, there was a significant gait speed reduction<br />
of 0.07 m/s (±0.09) from peak to end (0.82 m/s ±0.36) during the 6MWT, indicating an<br />
inability to sustain speed. These findings were most evident in Unlimited Community<br />
Ambulators (CA) (10MWT 1.38 m/s; 6MWT peak 1.15, end 1.07), followed by<br />
Limited CA (10MWT 0.71 m/s; 6MWT peak 0.61, end 0.55), while Household<br />
Ambulators showed no differences (10MWT 0.34 m/s; 6MWT peak 0.30, end 0.28).<br />
The total distance walked during the 6MWT (277.7 m ±135.5) was significantly less<br />
than the estimated distance (320.9 m ±138.2) based on peak speed. Subjects also<br />
displayed a significant increase in Rating of Perceived Exertion at the end (8 ±3 to 12<br />
±4) of the 6MWT. These indicate that the declining gait speed occurred with increased<br />
exertion and a reduction in total distance walked.<br />
CONCLusION: Individuals with chronic stroke could not sustain their gait speed<br />
for extended walking, which was associated with increased exertion and a reduction<br />
in estimated total distance walked. As these differences were primarily observed in<br />
Unlimited and Limited CA subgroups, community ambulation potential might be<br />
incomplete without assessing gait speed sustainability.<br />
1530 Board #122 May 30, 2:00 PM - 3:30 PM<br />
Investigating The Walking ability Of Patients With<br />
Parkinson’s disease Via Non-motorized Treadmills<br />
Han-Wen Chang1 , Wen-Hsu Sung1 , Tien-Yow Chuang2 .<br />
1 2 National Yang-Ming University, Taipei, Taiwan. Taipei Veterans<br />
General Hospital, Taipei, Taiwan.<br />
(No relationships reported)<br />
Decreased walking ability of patients with Parkinson’s disease (PD) may result in the<br />
limitations of activity of daily living. Non-motorized treadmills (NMTs) can provide<br />
active walking training. Subjects need to exert force from lower limbs to drive the belt<br />
forward to walk on it. Currently there are still few studies on the application of NMTs,<br />
especially on patients with PD.<br />
PurPOsE: The purpose of this study is to investigate the walking ability of patients<br />
with PD and to compare the walking ability between healthy adults and the patients<br />
with PD via NMTs.<br />
METhOd: Six healthy adults (group A) and six patients with PD (group B) were<br />
recruited. Group B was assessed during on-period (in 2 hours after taking medicine).<br />
Subjects were asked to walk on the NMT at self-paced speed and at as fast as possible<br />
speed for 1 minute respectively. We acquired the data of walking velocity, cadence,<br />
step length, and ground reaction force (GRF, which was normalized to body weight<br />
and conveyed to %BW). Independent sample t-test was used to analyze the data.<br />
Statistical significance was set at level of 0.05.<br />
rEsuLT: The mean age (y/o) (70.83±3.60 vs. 72.08±5.55; p=.654), height (cm)<br />
(161.33±11.27 vs. 161.83±8.86; p=.934), and weight (kgw) (61.67 ±11.48 vs.<br />
68.67±11.22; p=.311) between two groups were shown no significant difference.<br />
At self-paced speed, parameters of group A & group B: walking velocity (m/sec) is<br />
0.58±0.13 vs. 0.47±0.25 (p=.395); cadence (step/min) is 98.00±18.85 vs.100.50±18.76<br />
(p=.823); step length (m) is 0.36±0.10 vs. 0.28±0.10 (p=.185); GRF (%BW) is<br />
1.16±0.36 vs. 1.02±0.03 (p=.381). At fast speed, parameters of the two groups:<br />
walking velocity (m/sec) is 0.86±0.12 vs. 0.60±0.31 (p=.101); cadence (step/min) is<br />
122.00±17.66 vs. 124.50±20.50 (p=.826); step length (m) is 0.43±0.11 vs. 0.29±0.12<br />
(p=.054); GRF (%BW) is 1.16±0.34 vs. 1.03±0.02 (p=.401). There was no significant<br />
difference in these parameters between two groups.<br />
CONCLusION: The parameters revealed no significant difference between groups.<br />
However, the walking velocity of group B was slower than group A (self-paced<br />
MEDICINE & SCIENCE IN SPORTS & EXERCISE ®<br />
speed & as fast as possible speed: 82.32% & 69.50% respectively); step length was<br />
decreased (76.85% & 65.77% resp.); GRF is decreased (87.94% & 88.91% resp.).<br />
Our preliminary results may be a reference for the further NMT training on patients<br />
with PD.<br />
1531 Board #123 May 30, 2:00 PM - 3:30 PM<br />
Validity of handgrip Exercise to study Vascular Function in<br />
Parkinson’s disease<br />
Kylene Peroutky, Brandon Pollock, Keith Burns, John<br />
McDaniel, Angela Ridgel. Kent State University, Kent, OH.<br />
(Sponsor: Ellen L Glickman, FACSM)<br />
(No relationships reported)<br />
BaCKGrOuNd: Parkinson’s disease (PD) is a degenerative disorder of the central<br />
nervous system characterized by symptoms of motor dysfunction including tremors,<br />
impaired gait, and rigidity. Although autonomic dysfunction impairs the regulation<br />
of the cardiovascular system and oxidative stress may be associated with peripheral<br />
vascular dysfunction in this population, blood flow limitations during exercise and the<br />
extent of vascular dysfunction has yet to be established. Although handgrip exercise is<br />
a common modality used to evaluate blood flow and vascular function during exercise,<br />
the impaired motor control of this population may prevent from being a valid testing<br />
modality. PUPROSE: This study was used to validate whether the PD group was<br />
capable of performing consistent handgrip contractions over a prolonged duration and<br />
across various intensities.<br />
METhOds: Ten volunteers, 5 with PD and 5 controls matched for age performed a<br />
four stage handgrip protocol. Each participant was instructed to squeeze a handgrip<br />
dynamometer once per second for 3 minutes at 4 different intensities (30, 60, 90, and<br />
120 N). The subjects had real-time visual feedback of the force tracings during the<br />
entire protocol as well as a horizontal guideline which represented the target force.<br />
rEsuLTs: Statistical analysis indicated that across the entire protocol there was<br />
no difference in the percentage of contractions between the control (63.3±7.8%) and<br />
PD (69.7±9.9%) groups that were within 10% of the target force. There was also no<br />
statistical significance in the absolute error between the control (3.6±1.4 N, 5.6±0.84<br />
N, 7.7±0.90 N, 10.8±3.4 N) and PD (2.9±0.79 N, 5.3±1.03 N, 7.2±1.5 N, 8.2±1.3<br />
N) groups for the 4 levels of increasing intensity, respectively. In addition, although<br />
the duration of the contraction increased from Stage 1 to Stage 4 for both groups<br />
(approximately 298 ms to 534 ms) there was no statistical difference between the<br />
healthy controls and PD.<br />
CONCLusION: The results of this study indicate that the PD patients are capable<br />
of performing the handgrip exercise to the same aptitude as the control group. This<br />
suggests that the handgrip protocol is a valid method that can be used to evaluate<br />
vascular health and blood flow in PD patients compared to controls.<br />
1532 Board #124 May 30, 2:00 PM - 3:30 PM<br />
Loading asymmetry during the sit to stand in People with<br />
Multiples sclerosis<br />
Bradley J. Bowser 1 , Cathleen N. Brown 2 , Lesley J. White,<br />
FACSM 2 , Simpson J. Simpson, FACSM 2 . 1 South Dakota State<br />
University, Brookings, SD. 2 University of Georgia, Athens, GA.<br />
(No relationships reported)<br />
Mediolateral (ML) postural instability for people with multiple sclerosis (MS) is<br />
largely influenced by interlimb loading asymmetries. During quiet standing, people<br />
with MS favor their stronger limb by shifting their center of pressure towards the<br />
stronger leg side and simultaneously increasing the vertical ground reaction forces<br />
(GRF) to that leg. While ML postural stability and loading asymmetries have been<br />
examined during quiet standing, no research has examined these two variables during a<br />
sit to stand (STS) movement.<br />
PurPOsE: To compare ML stability and loading asymmetry between MS and non-<br />
MS persons during a STS movement.<br />
METhOds: Participants were divided into three groups: an MS group with leg<br />
weakness, less than 1.4 BW on 1RM leg press (MS-LW; n = 10; 49 ± 10 yr), an MS<br />
group with comparable strength to controls, greater than 1.4 BW on 1RM leg press<br />
(MS-CS; n = 11; 40 ± 12 yr), and a non-MS control group (CON; n = 12; 43 ± 12 yr).<br />
GRFs were captured bilaterally during five STS trials. ANOVAs followed by post-hoc<br />
testing (α = 0.05) were used to determine group differences for the variables of interest<br />
displayed in Table 1.<br />
rEsuLTs: Significant group differences for 1RM leg press, RLA, and ML stability<br />
were revealed (Table 1). Post-hoc comparisons indicate lower 1RM leg press and<br />
increased ML instability for MS-LW compared to both CON and MS-CS (Table 1).<br />
RLA was also higher in MS-LW compared to CON (Table 1).<br />
CONCLusION: During the STS, persons with MS who have leg weakness display<br />
greater ML instability that is likely due to greater vertical loading occurring on the<br />
dominant/stronger limb. MS training protocols that emphasize both strength and<br />
symmetry training may be needed in order to improve ML stability during dynamic<br />
movements such as the STS.<br />
ACSM May 28 - June 1, 2013 Indianapolis, Indiana